1. Home
  2. PGNY vs AVDL Comparison

PGNY vs AVDL Comparison

Compare PGNY & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Progyny Inc.

PGNY

Progyny Inc.

HOLD

Current Price

$26.24

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.43

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGNY
AVDL
Founded
2008
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
PGNY
AVDL
Price
$26.24
$21.43
Analyst Decision
Buy
Buy
Analyst Count
9
9
Target Price
$27.44
$18.38
AVG Volume (30 Days)
1.5M
2.8M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
2.96
N/A
EPS
0.62
N/A
Revenue
$1,268,689,000.00
$248,517,000.00
Revenue This Year
$11.55
$65.47
Revenue Next Year
$9.52
$30.88
P/E Ratio
$43.27
N/A
Revenue Growth
11.41
79.88
52 Week Low
$13.86
$6.38
52 Week High
$27.51
$23.57

Technical Indicators

Market Signals
Indicator
PGNY
AVDL
Relative Strength Index (RSI) 63.07 59.42
Support Level $23.78 $21.34
Resistance Level $25.27 $21.55
Average True Range (ATR) 0.86 0.24
MACD -0.05 -0.24
Stochastic Oscillator 69.55 13.46

Price Performance

Historical Comparison
PGNY
AVDL

About PGNY Progyny Inc.

Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: